Overview

Brain Markers of Anxiety Disorders and SSRI/CBT Treatment in Children and Adolescents

Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
This study will attempt to identify gene and brain activity markers that predict whether children and adolescents with anxiety disorders will respond to selective serotonin reuptake inhibitor medications or Cognitive Behavioral Therapy (CBT).
Details
Lead Sponsor:
University of Michigan
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Sertraline